Latest filing published 14 Aug 2025 for IGM Biosciences, Inc.. Read the official filing
All filings by Mary Beth Harler on record concern IGM Biosciences, Inc. Between 14 June 2024 and 14 August 2025, the trades on record add up to 9 filings.
The open-market record consists of 6 sales worth €64k, with no purchase. Outside the open market, there are 2 share grants. Since January 2025: no purchases and 3 sales on the market.
On 14 August 2025 came the latest disclosure, a transaction in IGM Biosciences, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 5 declarations